Citadel Advisors
KZIA

Citadel Advisors’s Kazia Therapeutics KZIA Stock Holding History

Citadel Advisors’s Portfolio KZIA Stock Details KZIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$401K Buy
+28,509
New +$347K ﹤0.01% 10419
2024
Q4 		– Sell
-1,210
Closed -$26K – 14982
2024
Q3 		$26K Buy
1,210
+1,119
+1,230% +$22.3K ﹤0.01% 12568
2024
Q2 		$1.04K Buy
+91
New +$1.35K ﹤0.01% 13870
2024
Q1 		– Sell
-256
Closed -$5.75K – 15072
2023
Q4 		$5.75K Buy
+256
New +$7.49K ﹤0.01% 13405
2022
Q3 		– Sell
-455
Closed -$50.9K – 13157
2022
Q2 		$95K Buy
+455
New +$140K ﹤0.01% 11465
2021
Q4 		– Sell
-352
Closed -$176K – 14331
2021
Q3 		$202K Buy
352
+96
+38% +$47.2K ﹤0.01% 11965
2021
Q2 		$126K Buy
+256
New +$135K ﹤0.01% 12694
2019
Q4 		– Sell
-256
Closed -$49K – 9449
2019
Q3 		$49K Sell
256
-153
-37% -$20.9K ﹤0.01% 8711
2019
Q2 		$49K Buy
+409
New +$62.9K ﹤0.01% 8735
2017
Q3 		– Sell
-90
Closed -$16K – 7789
2017
Q2 		$16K Buy
90
+26
+41% +$4.91K ﹤0.01% 7331
2017
Q1 		$18K Buy
+64
New +$20.2K ﹤0.01% 7273
2016
Q4 		– Sell
-88
Closed -$35K – 7579
2016
Q3 		$35K Buy
+88
New +$34.3K ﹤0.01% 6931
2015
Q3 		– Sell
-61
Closed -$49K – 9071
2015
Q2 		$49K Buy
+61
New +$69.2K ﹤0.01% 7668
2014
Q2 		– Sell
-63
Closed -$52K – 8135
2014
Q1 		$52K Buy
+63
New +$53.7K ﹤0.01% 6752

Other funds holding KZIA

BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
FLPIM
F.L. Putnam Investment Management Lynnfield, Massachusetts $8.39B AUM 37.75% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
DIG
Dauntless Investment Group Etna, New Hampshire $127M AUM 42.43% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $60.8B AUM 42.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Citadel Advisors's KZIA Position: Q2 2026 in Review

Citadel Advisors opened a new position in Kazia Therapeutics (KZIA) in Q2 2026: 28,509 shares worth $401K. The stake represents ﹤0.01% of the portfolio and ranks #10419 among its holdings. This is a return to the name: Citadel Advisors previously reported a position in KZIA as recently as Q3 2024.

Citadel Advisors first reported a position in KZIA in Q1 2014 and has held it in 14 quarters since. 35 funds tracked by Wall St. Rank hold KZIA as of Q2 2026.

  • Citadel Advisors held 28,509 shares of Kazia Therapeutics worth $401K as of Q2 2026.
  • Kazia Therapeutics was a new Citadel Advisors position in Q2 2026.
  • Kazia Therapeutics made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #10419 holding.
  • Citadel Advisors first reported a position in Kazia Therapeutics in Q1 2014 and has held it in 14 quarters since.
  • 35 funds tracked by Wall St. Rank held Kazia Therapeutics as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.